Skip to Main Content

Author Details

Jennifer Dunlap
Oregon Health & Science University
2008
44
18
PMIDPaper TitleJournal TitlePublished Year
34081042PSEUDOPANUVEITIS AS A HARBINGER FOR SYSTEMIC LEUKEMIA RECURRENCE.Retin Cases Brief Rep2023
37685882Cytogenetically Cryptic Acute Promyelocytic Leukemia: A Diagnostic Challenge.Int J Mol Sci2023
36441905Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.Blood Adv2023
35258401Adult acute myeloid leukemia patients with <i>NUP98</i> rearrangement have frequent cryptic translocations and unfavorable outcome.Leuk Lymphoma2022
33961341Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations.Am J Transplant2021
33901720Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.Transplant Cell Ther2021
34559205In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported.Blood Adv2021
32242922Mast cell sarcoma with concurrent mast cell leukaemia.Br J Haematol2020
31866570Molecular Discordance between Myeloid Sarcomas and Concurrent Bone Marrows Occurs in Actionable Genes and Is Associated with Worse Overall Survival.J Mol Diagn2020
31880950Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.J Clin Oncol2020
31145495The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML.Am J Hematol2019
30810217Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed-CD19 selective pressure.Br J Haematol2019
28868942MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypes.Leuk Lymphoma2018
29892546Acute promyelocytic leukemia presenting with features of metastatic osseous disease.Leuk Res Rep2018
29959414Discriminating a common somatic ASXL1 mutation (c.1934dup; p.G646Wfs*12) from artifact in myeloid malignancies using NGS.Leukemia2018
29472351Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort.Haematologica2018
29199519Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma.Leuk Lymphoma2018
29323794Skills transfer to sinus surgery via a low-cost simulation-based curriculum.Int Forum Allergy Rhinol2018
29165010DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML.Leuk Lymphoma2018
28476053Transmission of Donor-Derived Breast Carcinoma as a Recurrent Mass in a Keratolimbal Allograft.Cornea2017
28248816TdT-positive Infiltrate in Inflamed Pediatric Kidney: A Potential Diagnostic Pitfall.Am J Surg Pathol2017
27036514Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent.J Hematol Oncol2016
26573090Mutant calreticulin-expressing cells induce monocyte hyperreactivity through a paracrine mechanism.Am J Hematol2016
27671675FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia.Cancer Res2016
27124934Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.Am J Clin Pathol2016
27235757Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women.Exp Hematol2016
25432174Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance.Cancer Res2015
24408322Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations.Blood2014
25628989Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndrome.Leuk Res Rep2014
25125625Aberrations of MYC are a common event in B-cell prolymphocytic leukemia.Am J Clin Pathol2014
24637335Functional integration of acute myeloid leukemia into the vascular niche.Leukemia2014
22767020A germline-competent embryonic stem cell line from NOD.Cg-Prkdc ( scid ) Il2rg ( tm1Wjl )/SzJ (NSG) mice.Transgenic Res2013
24319570Diffuse large B-cell lymphoma in adults aged 75 years and older: a single institution analysis of cause-specific survival and prognostic factors.Ther Adv Hematol2013
22425895Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia.Leukemia2012
22658276Multiplex high-throughput gene mutation analysis in acute myeloid leukemia.Hum Pathol2012
21502425Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms.Am J Clin Pathol2011
19418217Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma.Breast Cancer Res Treat2010
20672048Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients.Adv Hematol2010
19898424High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast.Mod Pathol2010
20068453Estrogen is renoprotective via a nonreceptor-dependent mechanism after cardiac arrest in vivo.Anesthesiology2010
19737647Cytogenetic analysis of a primary bone angiosarcoma.Cancer Genet Cytogenet2009
17728042Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation.Resuscitation2008
18706749Rejection versus posttransplantation lymphoproliferative disorder in a renal transplant recipient.Am J Kidney Dis2008
18635495Renal ischemia: does sex matter?Anesth Analg2008
  • 1 - 44 of 44

Recommended Authors

Bartlomiej Przychodzen
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 0
Alexa J Siddon
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 3
Amanda Winters
University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 1
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 0
Felicitas Thol
Hannover Medical School
Career Start Year 2007
Number of shared co-authors 3
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 4
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 15
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 1
Thomas Ernst
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 3
Gudrun G??hring
Hannover Medical School
Career Start Year 2002
Number of shared co-authors 2
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 6
Ravindra Majeti
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 4
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 4
Mignon L Loh
University of Washington
Career Start Year 1998
Number of shared co-authors 17
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 5
Yongjin Li
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 5
Lucy A Godley
The University of Chicago
Career Start Year 1994
Number of shared co-authors 9
Timothy A Graubert
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 6
Michael Heuser
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 5
Seishi Ogawa
Kyoto University
Career Start Year 1993
Number of shared co-authors 4
Jean Soulier
University of Paris
Career Start Year 1993
Number of shared co-authors 5
Derek L Stirewalt
Fred Hutchinson Cancer Center
Career Start Year 1992
Number of shared co-authors 7
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 0
Christopher D Gocke
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 2
Claude Preudhomme
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Career Start Year 1989
Number of shared co-authors 1
Mark J Routbort
University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 3
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 5
Soheil Meshinchi
Fred Hutchinson Cancer Research Centre
Career Start Year 1987
Number of shared co-authors 15
Torsten Haferlach
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 1983
Number of shared co-authors 6

Collaborators

Guang Fan
Oregon Health and Science University
Co-authored papers 18
Richard D Press
Oregon Health and Science University
Co-authored papers 17
Elie Traer
Oregon Health & Science University
Co-authored papers 13
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 9
Brian J Druker
Oregon Health & Science University
Co-authored papers 8
Jessica Leonard
Oregon Health & Science University
Co-authored papers 7
Richard T Maziarz
Oregon Health & Science University
Co-authored papers 6
Christopher L Corless
Oregon Health & Science University
Co-authored papers 5
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Laura F Newell
Oregon Health and Science University
Co-authored papers 4
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Kim-Hien T Dao
Astex Pharmaceuticals
Co-authored papers 3
Jacqueline Martinez
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Rachel J Cook
Oregon Health and Science University
Co-authored papers 3
Hyunjung Lee
Oregon Health & Science University, Knight Cancer Institute
Co-authored papers 3
Stephen E Spurgeon
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 3
Fei Yang
Oregon Health & Science University
Co-authored papers 3
Ronan Swords
Oregon Health and Science University
Co-authored papers 2
Tauangtham Anekpuritanang
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Isabel English
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Gabrielle Meyers
Oregon Health and Science University
Co-authored papers 2
Julia E Maxson
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Brandon Hayes-Lattin
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 2
Grover C Bagby
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 2
Melissa H Wong
Oregon Health & Science University
Co-authored papers 2
William H Fleming
Oregon Health & Science University
Co-authored papers 2
Richard J Traystman
University of Colorado
Co-authored papers 1
Atiya Mansoor
Oregon Health & Science University
Co-authored papers 1
Stephen T Oh
Washington University School of Medicine
Co-authored papers 1
Robert H Collins
University of Texas Southwestern Medical Center
Co-authored papers 1
Release 1.2